Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by StockinFockeron May 29, 2015 4:09am
127 Views
Post# 23776874

RE:RE:Simple people

RE:RE:Simple people
knoll wrote: maybe someone can clear this up for me.

As per last NR I was under the impression they were awaiting the NOC (Notice of Compliance) before they can sell ..."The NOC from Health Canada provides the authorization for VANC to market and sell the generic molecules in Canada". Is it safe to assume they got that already. I bring this up because a few post back it was said that they seen it in pharma already. I imagine this would have been news worth - no?

... and ya why not pink. Pepto Bismol comes in a pink bottle and it sells.




The NOC for the drugs that Vanc is taking delivery of and shipping to customers this quarter was received from Health Canada last year - see below NRs:

VANC PHARMACEUTICALS RECEIVES HEALTH CANADA APPROVAL FOR 22 GENERIC MOLECULES - (2014-11-18):
https://www.vancpharm.com/wp-content/uploads/2014/11/Vanc-2014-11-18-News-Release.pdf

VANC PHARMACEUTICALS RECEIVES HEALTH CANADA APPROVAL FOR 7 ADDITIONAL GENERIC MOLECULES - (2014-12-16):
https://www.vancpharm.com/wp-content/uploads/2014/12/2014-12-16-News-Release-announcing-additional-molecules.pdf

As drliquid has already pointed out they are waiting for the NOC from Health Canada for just the 5 new generic molecules.

Bullboard Posts